171 related articles for article (PubMed ID: 3592866)
1. Bronchodilator and other pharmacological activities of R-836 (2,5-diethyl-7-(4-thiomorpholino)-1,2,4-triazolo[1,5-c]pyrimidin e).
Swingle KF; Hammerbeck DM; Schmid JR; Stelzer VL; Reiter MJ; Peterson AM; Wade JJ
Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):255-71. PubMed ID: 3592866
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
Howell RE; Sickels BD; Woeppel SL
J Pharmacol Exp Ther; 1993 Feb; 264(2):609-15. PubMed ID: 8437112
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
Yamada N; Yamada K; Takahashi K; Nakao E; Kadowaki S; Umezu K
Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
[TBL] [Abstract][Full Text] [Related]
4. Trachea relaxing effects and beta2-selectivity of SPFF, a newly developed bronchodilating agent, in guinea pigs and rabbits.
Gan LL; Wang MW; Cheng MS; Pan L
Biol Pharm Bull; 2003 Mar; 26(3):323-8. PubMed ID: 12612441
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and toxicological studies of an original xanthine derivative with bronchodilatating activity.
Staneva D; Chakurova L; Ivanova N; Spasov V; Raynova L; Bogoslovova T
Acta Physiol Pharmacol Bulg; 1984; 10(4):44-52. PubMed ID: 6535369
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies on BB-1502, a new bronchodilator.
Kamei H; Hirano M; Kawano K; Murata S; Imanishi H; Kawaguchi H
Jpn J Pharmacol; 1981 Jun; 31(3):333-46. PubMed ID: 6273627
[TBL] [Abstract][Full Text] [Related]
7. New pharmacological data on the bronchospasmolytic activity of bamifylline.
Berti F; Magni F; Rossoni G; Schiantarelli P; Bongrani S; Pasargiklian R
Arzneimittelforschung; 1988 Jan; 38(1):40-4. PubMed ID: 3365275
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study on the action mechanism of a new bronchodilator agent, BB-1502].
Kamei H; Obi Y; Kawano K; Hirano M; Murata S; Imanishi H
Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):335-42. PubMed ID: 6200410
[TBL] [Abstract][Full Text] [Related]
9. Comparison of animal models for predicting bronchodilator efficacy in man.
Spilker B; Minatoya H; McKeon WB
Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):218-35. PubMed ID: 1190917
[TBL] [Abstract][Full Text] [Related]
10. Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig.
Underwood DC; Bochnowicz S; Osborn RR; Kotzer CJ; Luttmann MA; Hay DW; Gorycki PD; Christensen SB; Torphy TJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):988-95. PubMed ID: 9864284
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic potency and selectivity of a new bronchodilator agent, 2,3-dihydro-7-methyl-9-phenyl-1H-pyrazolo [1,2-a] indazolium bromide (FKK) on canine tracheal preparations "in vivo" and "in vitro".
Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):150-63. PubMed ID: 6870387
[TBL] [Abstract][Full Text] [Related]
12. [Effect of a new bronchodilator, S-1540 (Bitolterol) and S-1541 on the tracheo-bronchial and cardiovascular system].
Ono N; Kushiku K; Morishita H; Nakagami K; Nakahara T
Nihon Yakurigaku Zasshi; 1975 Oct; 71(7):739-52. PubMed ID: 1240071
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic studies on W10,294A, a new bronchodilator.
Giles RE; Williams JC; Finkel MP
J Pharmacol Exp Ther; 1977 Dec; 203(3):701-11. PubMed ID: 21958
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
Underwood DC; Osborn RR; Novak LB; Matthews JK; Newsholme SJ; Undem BJ; Hand JM; Torphy TJ
J Pharmacol Exp Ther; 1993 Jul; 266(1):306-13. PubMed ID: 8392555
[TBL] [Abstract][Full Text] [Related]
15. [Bronchodilator actions of diltiazem in vitro and in vivo (author's transl)].
Nagao T; Iwasawa Y; Ikezawa K; Murata S; Sato M
Nihon Yakurigaku Zasshi; 1981 May; 77(5):553-8. PubMed ID: 7297962
[TBL] [Abstract][Full Text] [Related]
16. Multiple mechanisms of xanthine actions on airway reactivity.
Howell RE
J Pharmacol Exp Ther; 1990 Dec; 255(3):1008-14. PubMed ID: 2175791
[TBL] [Abstract][Full Text] [Related]
17. The effects of methylxanthines, ethymizol, ephedrine and papaverine on guinea pig and dog trachea.
Bilcíková L; Bauer V; Kolena J
Gen Physiol Biophys; 1987 Apr; 6(2):137-48. PubMed ID: 2820837
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor-acether-induced relaxation of guinea pig airway muscle: role of prostaglandin E2 and the epithelium.
Brunelleschi S; Haye-Legrand I; Labat C; Norel X; Benveniste J; Brink C
J Pharmacol Exp Ther; 1987 Oct; 243(1):356-63. PubMed ID: 3478474
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.
Hay DW; Muccitelli RM; Tucker SS; Vickery-Clark LM; Wilson KA; Gleason JG; Hall RF; Wasserman MA; Torphy TJ
J Pharmacol Exp Ther; 1987 Nov; 243(2):474-81. PubMed ID: 2824747
[TBL] [Abstract][Full Text] [Related]
20. The use of the in vivo trachea preparation of the guinea-pig to asses drug action on lung.
James GW
J Pharm Pharmacol; 1969 Jun; 21(6):379-86. PubMed ID: 4389171
[No Abstract] [Full Text] [Related]
[Next] [New Search]
